FlawCheck Citator
Check how courts have cited this case. Use our
free citator for the most current treatment.
No. 7454724
United States Court of Appeals for the Fourth Circuit
Eli Lilly and Company v. Novartis Pharma AG
No. 7454724 · Decided June 16, 2022
No. 7454724
·
Fourth Circuit · 2022
·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Fourth Circuit
Decided
June 16, 2022
Citation
No. 7454724
Disposition
See opinion text.
Full Opinion
Plain English Summary
Plain-English summary coming soon. Read the opinion text below for the current holding.
Frequently Asked Questions
Eli Lilly and Company v. Novartis Pharma AG is a decision of the Fourth Circuit. Review the opinion text below for the holding.
FlawCheck shows no negative treatment for Eli Lilly and Company v. Novartis Pharma AG in the current circuit citation data.
This case was decided on June 16, 2022.
Use the citation No. 7454724 and verify it against the official reporter before filing.
Why Attorneys Choose FlawFinder
| Feature |
FlawFinder |
Westlaw |
LexisNexis |
| Monthly price | $19 – $99 | $133 – $646 | $153 – $399 |
| Contract | None | 1–3 year min | 1–6 year min |
| Hidden fees | $0, always | Up to $469/search | $25/mo + per-doc |
| FlawCheck citator | Included | KeyCite ($$$) | Shepard's ($$$) |
| Plain-English summary | Included | No | No |
| Cancel | One click | Termination fees | Account friction |
Related Cases
Full legal research for $19/month
All 50 states · Federal regulations · Case law · Police SOPs · AI analysis included · No contract
Continue Researching →